Trial Financial Management White Papers & Case Studies
-
Contract & Regulatory Services Brochure
8/29/2012
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones—including drug shipment, IRB approval, and patient randomization—can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents.
-
Global Payment Services Brochure
8/29/2012
Biopharmaceutical and medical device companies rely on investigative sites to complete their clinical trials. Building strong relationships with high-quality sites is critical to addressing a number of key challenges – from the growing number of trials to mounting pressures to minimize cycle times. Yet investigative sites increasingly denounce unrealistic payment schedules and inefficient payment processes as not only frustrating but also threatening to their financial viability.
-
The Sunshine Act: What Sponsors And CROs Should Know
3/27/2012
There was a lack of concentration and information on HCP Aggregate Spend (the Sunshine Act and PPSA are other terms used to describe it) at the annual Partnerships in Clinical Trials conference in Orlando. It was as if the whole industry is ignoring the issue hoping it will simply disappear.
-
Employee-Driven Change Management Takes Copernicus Group IRB Completely Paperless
12/29/2011
Copernicus Group IRB (CGIRB), with assistance from Sitrof and employee-driven change management, was able to transform from an entirely paper-reliant company with millions of pages of legacy documentation into a completely digital paperless organization in less than two years.
-
Clinical Smarter Trials
5/11/2011
Clinical development today takes longer, and it costs more. R&D productivity is declining. Pipelines are thinner. New regulatory demands are adding another layer of complexity.
-
Advancing Vaccine Development
5/11/2011
With extensive experience in vaccines development, as well as market access and commercialization strategy, Quintiles is uniquely qualified to be your ally in vaccines.